Low Dose of Aspirin Found to Reduce Colon Cancer

by: cancercompass

A new study found that a low dose of aspirin could cut colon cancer cases by a quarter. The study consisted of four trials over 20 years, analyzing more than 14,000 people. It compared those taking a low dose of aspirin to those taking a placebo or nothing.

According to the Washington Post, the study found people taking baby or regular aspirin pills daily for about six years reduced their colon cancer risk by 24 percent and that deaths from the disease dropped by 35 percent.

"This is proof that low-dose aspirin prevents colorectal cancer," Dr. Peter Rothwell, a professor of neurology at John Radcliffe Hospital and the University of Oxford in the U, told BusinessWeek. "Somewhat fortuitously, it mainly prevents those cancers that are least well-prevented by screening colonoscopy."

However, Dr. Robert Benamouzig, from the Department of Gastroenterology at Avicenne Hospital in Bobigny, France, and author of an accompanying journal editorial, warns that only those with a high risk for colorectal cancer should start taking aspirin. When taken in high doses over a long period of time, aspirin can irritate the stomach and lead to gastrointestinal bleeding.

To learn more about the cancer featured in this post, please visit our colon cancer information page.